Ìtọjú àrùn jẹjẹrẹ ọmú sinmi lórí onírúurú nǹkan bíi ipele àrùn jẹjẹrẹ, irú àrùn jẹjẹrẹ tó wà, ìlera aláìsàn náà, àti ohun tóun fúnra rẹ̀ fẹ́.
Lára àwọn ìtọ́jú tó wọ́pọ̀ ni:
1. Ìṣẹ́ abẹ: Èyí ní í ṣe pẹ̀lú fífi kòkòrò náà àti ẹ̀jẹ̀ tó yí i ká kúrò.
Oríṣi iṣẹ́ abẹ ọ̀tọ̀ọ̀tọ̀ ló wà, títí kan iṣẹ́ abẹ tí wọ́n ń pè ní lumpectomy, mastectomy, àti iṣẹ́ abẹ tí wọ́n ń pè ní lymph node removal.
2. Ìtọ́jú nípa ìmọ́lẹ̀: Ìtọ́jú yìí máa ń lo ìmọ́lẹ̀ tó lágbára gan-an láti pa àwọn sẹ́ẹ̀lì àrùn jẹjẹrẹ, kí wọ́n sì dín àwọn àrùn jẹjẹrẹ kù.
Wọ́n sábà máa ń lò ó lẹ́yìn iṣẹ́ abẹ láti pa àwọn sẹ́ẹ̀lì àrùn jẹjẹrẹ tó bá ṣẹ́ kù.
3. Ìtọ́jú oògùn olóró: Èyí ní í ṣe pẹ̀lú lílo oògùn láti pa àwọn sẹ́ẹ̀lì àrùn jẹjẹrẹ.
Wọ́n máa ń lò ó láti dín àwọn kòkòrò tó wà nínú ara kù kí wọ́n tó ṣe iṣẹ́ abẹ tàbí láti pa àwọn sẹ́ẹ̀lì àrùn jẹjẹrẹ tó bá ṣẹ́ kù lẹ́yìn iṣẹ́ abẹ.
4. Ìtọ́jú Hormone: Wọ́n máa ń lò ó fún àwọn àrùn jẹjẹrẹ ọmú tí wọ́n ń pè ní hormone-receptor-positive, ó sì máa ń dí àwọn èròjà tó ń mú kí àwọn sẹ́ẹ̀lì àrùn jẹjẹrẹ máa pọ̀ sí i lọ́wọ́.
5. Ìtọ́jú tí wọ́n ń darí: Èyí máa ń lo àwọn oògùn tó máa ń darí àwọn èròjà kan pàtó tó máa ń mú kí àwọn sẹ́ẹ̀lì àrùn jẹjẹrẹ dàgbà, tí wọ́n sì máa ń tàn kálẹ̀.
6. Ìdènà àrùn: Èyí máa ń ran ètò ààbò lọ́wọ́ láti mọ àwọn sẹ́ẹ̀lì àrùn jẹjẹrẹ, kó sì gbéjà kò wọ́n.
7. Ìdánwò ilé ìwòsàn: Àwọn aláìsàn tún lè ronú láti kópa nínú ìdánwò ilé ìwòsàn láti rí àwọn ìtọ́jú tuntun àti ìdánwò.
Ó ṣe pàtàkì láti jíròrò àwọn ọ̀nà ìtọ́jú tó dára jù lọ pẹ̀lú ẹgbẹ́ olùtọ́jú ìlera, nítorí pé ètò ìtọ́jú náà yóò wà ní ìbámu pẹ̀lú àwọn ohun tí ẹnì kọ̀ọ̀kan nílò àti ipò tó wà.
Yàtọ̀ síyẹn, ìtọ́jú tó máa ń ràn ẹ́ lọ́wọ́, irú bí ìtọ́jú ìrora, ìtìlẹ́yìn nípa èrò inú, àti ìtọ́sọ́nà nípa oúnjẹ jẹun tún lè jẹ́ apá kan ètò ìtọ́jú náà.
Kumar L, Baldi A, Verma S, Utreja P: Exploring Therapeutic Potential of Nanocarrier Systems Against Breast Cancer. Pharm Nanotechnol. 2018, 6 (2): 94-110.
Mehrgou A, Akouchekian M: Therapeutic impacts of microRNAs in breast cancer by their roles in regulating processes involved in this disease. J Res Med Sci. 2017, 22 (): 130.
Ng AK, Travis LB: Radiation therapy and breast cancer risk. J Natl Compr Canc Netw. 2009, 7 (10): 1121-8.
Ligresti G, Libra M, Militello L, Clementi S, Donia M, Imbesi R, Malaponte G, Cappellani A, McCubrey JA, Stivala F: Breast cancer: Molecular basis and therapeutic strategies (Review). Mol Med Rep. , 1 (4): 451-8.
Bricou A, Barranger E: Response to the article by Evangelista et al.: Use of a portable gamma camera for guiding surgical treatment in locally advanced breast cancer in a post-neoadjuvant therapy setting. Breast Cancer Res Treat 2014. Breast Cancer Res Treat. 2014, 148 (1): 231-2.
Daniyal A, Santoso I, Gunawan NHP, Barliana MI, Abdulah R: Genetic Influences in Breast Cancer Drug Resistance. Breast Cancer (Dove Med Press). 2021, 13 (): 59-85.
Li X, Bu X: Progress in Vaccine Therapies for Breast Cancer. Adv Exp Med Biol. 2017, 1026 (): 315-330.
Ìyàsímímọ́: ìtọ́jú ìlera
Oju opo wẹẹbu yii ni a pese fun eto-ẹkọ ati awọn idi alaye nikan ati pe ko ṣe agbekalẹ pese imọran iṣoogun tabi awọn iṣẹ ọjọgbọn.
A ò gbọ́dọ̀ lo ìsọfúnni tó wà nínú ìwé náà láti ṣe àyẹ̀wò tàbí láti wo àìsàn tàbí àìsàn kan wò, àwọn tó bá sì ń wá ìmọ̀ràn nípa ìṣègùn fúnra wọn gbọ́dọ̀ bá dókítà tó ní ìwé àṣẹ sọ̀rọ̀.
Jọwọ ṣe akiyesi nẹtiwọọki neural ti o ṣe agbejade awọn idahun si awọn ibeere, jẹ pataki ti ko tọ nigbati o ba de si akoonu nọmba. Fun apẹẹrẹ, nọmba awọn eniyan ti a ṣe ayẹwo pẹlu aisan kan pato.
Nigbagbogbo wa imọran ti dokita rẹ tabi olupese ilera ti o ni oye miiran nipa ipo iṣoogun kan. Maṣe gbagbe imọran iṣoogun ọjọgbọn tabi idaduro ni wiwa rẹ nitori nkan ti o ti ka lori oju opo wẹẹbu yii. Ti o ba ro pe o le ni pajawiri iṣoogun, pe 911 tabi lọ si yara pajawiri ti o sunmọ julọ lẹsẹkẹsẹ. Ko si ibatan dokita-aisan ti a ṣẹda nipasẹ oju opo wẹẹbu yii tabi lilo rẹ. Bẹni BioMedLib tabi awọn oṣiṣẹ rẹ, tabi ẹnikẹni ti o ṣe alabapin si oju opo wẹẹbu yii, ṣe eyikeyi awọn aṣoju, ṣalaye tabi tumọ, pẹlu ọwọ si alaye ti a pese nibi tabi lilo rẹ.
Ìyàsímímọ́: ẹ̀tọ́ ọmọnìyàn
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) n pese atunṣe fun awọn onihun aṣẹ-aṣẹ ti o gbagbọ pe ohun elo ti o han lori Intanẹẹti ṣe ilokulo awọn ẹtọ wọn labẹ ofin aṣẹ-aṣẹ AMẸRIKA.
Ti o ba gbagbọ ni igbagbọ to dara pe eyikeyi akoonu tabi ohun elo ti o wa ni asopọ pẹlu oju opo wẹẹbu wa tabi awọn iṣẹ ṣe ilokulo aṣẹ-aṣẹ rẹ, iwọ (tabi aṣoju rẹ) le firanṣẹ akiyesi kan si wa ti o beere pe a yọ akoonu tabi ohun elo naa kuro, tabi idilọwọ iraye si rẹ.
A gbọdọ firanṣẹ awọn iwifunni ni kikọ nipasẹ imeeli (wo abala "Ibaṣepọ" fun adirẹsi imeeli).
DMCA nilo pe akiyesi rẹ ti ilokulo aṣẹ-aṣẹ ti a fi ẹsun kan pẹlu alaye wọnyi: (1) apejuwe ti iṣẹ ti o ni aṣẹ-aṣẹ ti o jẹ koko-ọrọ ti ilokulo ti a fi ẹsun kan; (2) apejuwe ti akoonu ti a fi ẹsun kan ati alaye ti o to lati gba wa laaye lati wa akoonu naa; (3) alaye olubasọrọ fun ọ, pẹlu adirẹsi rẹ, nọmba foonu ati adirẹsi imeeli; (4) alaye nipasẹ rẹ pe o ni igbagbọ rere pe akoonu ni ọna ti o ni ẹsun ti ko ni aṣẹ nipasẹ eni aṣẹ-aṣẹ, tabi aṣoju rẹ, tabi nipasẹ iṣẹ ti ofin eyikeyi;
(5) ìpolongo kan láti ọ̀dọ̀ rẹ, tí o fìdí rẹ̀ múlẹ̀ lábẹ́ ìjìyà ẹ̀rí èké, pé ìsọfúnni tó wà nínú ìkéde náà tọ̀nà àti pé o ní àṣẹ láti mú kí àwọn ẹ̀tọ́ ọmọnìyàn tí wọ́n sọ pé wọ́n ti rú ṣẹ ṣẹ;
ati (6) ibuwọlu ti ara tabi itanna ti ẹni ti o ni aṣẹ tabi eniyan ti o ni aṣẹ lati ṣiṣẹ ni orukọ ẹni ti o ni aṣẹ.
Ti o ko ba ṣafikun gbogbo alaye ti o wa loke le ja si idaduro ti ṣiṣe ẹdun rẹ.
Ìfọ̀rọ̀wérọ̀
Jọwọ fi imeeli ranṣẹ si wa pẹlu eyikeyi ibeere / imọran.
How to treat breast cancer?
The treatment for breast cancer depends on various factors such as the stage of cancer, the type of cancer, the patient's overall health, and personal preferences.
Some common treatment options include:
1. Surgery: This involves removing the tumor and surrounding tissue.
There are different types of surgery, including lumpectomy, mastectomy, and lymph node removal.
2. Radiation therapy: This uses high-energy radiation to kill cancer cells and shrink tumors.
It is often used after surgery to kill any remaining cancer cells.
3. Chemotherapy: This involves using drugs to kill cancer cells.
It can be given intravenously or or orally and is often used to shrink tumors before surgery or to kill any remaining cancer cells after surgery.
4. Hormone therapy: This is used for hormone-receptor-positive breast cancers and works by blocking the hormones that fuel the growth of cancer cells.
5. Targeted therapy: This uses drugs that target specific molecules involved in the growth and spread of cancer cells.
6. Immunotherapy: This helps the immune system recognize and attack cancer cells.
7. Clinical trials: Patients may also consider participating in clinical trials to access new and experimental treatments.
It is important to discuss the best treatment options with a healthcare team, as the treatment plan will be tailored to the individual's specific needs and circumstances.
Additionally, supportive care such as pain management, emotional support, and nutritional guidance may also be part of the treatment plan.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Ní nǹkan bí
BioMedLib nlo awọn kọnputa adaṣe (awọn alugoridimu ẹkọ ẹrọ) lati ṣe agbejade awọn tọkọtaya ibeere ati idahun.
A bẹrẹ pẹlu awọn atẹjade biomedical miliọnu 35 ti PubMed/Medline. Pẹlupẹlu, awọn oju-iwe wẹẹbu ti RefinedWeb.
